Volume 187, Issue 6, Pages 2074-2081 (June 2012) The FinnProstate Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer Arto J. Salonen, Kimmo Taari, Martti Ala-Opas, Jouko Viitanen, Seppo Lundstedt, Teuvo L.J. Tammela The Journal of Urology Volume 187, Issue 6, Pages 2074-2081 (June 2012) DOI: 10.1016/j.juro.2012.01.122 Copyright © 2012 American Urological Association Education and Research, Inc. Terms and Conditions
Figure 1 Kaplan-Meier curves for PFS, OS, PCS and TF survival in intermittent and continuous treatment arms. Cum, cumulative. The Journal of Urology 2012 187, 2074-2081DOI: (10.1016/j.juro.2012.01.122) Copyright © 2012 American Urological Association Education and Research, Inc. Terms and Conditions
Figure 2 Kaplan-Meier curves for PFS, OS, PCS and TF survival by PSA at randomization in trial population. PSA less than 1.0 (206), 1.0 to 4.0 (229), greater than 4.0 ng/ml (118) with p values for log rank tests. Of 553 patients 1 refused intermittent trial therapy. Cum, cumulative. The Journal of Urology 2012 187, 2074-2081DOI: (10.1016/j.juro.2012.01.122) Copyright © 2012 American Urological Association Education and Research, Inc. Terms and Conditions
Figure 3 Kaplan-Meier curves for PFS, OS, PCS and TF survival by differentiation grade of Gleason scores 6–7 (205) and 8–10 (286). Log rank p <0.001. Cum, cumulative. The Journal of Urology 2012 187, 2074-2081DOI: (10.1016/j.juro.2012.01.122) Copyright © 2012 American Urological Association Education and Research, Inc. Terms and Conditions